Ieq Capital LLC Grows Stock Holdings in Pediatrix Medical Group, Inc. (NYSE:MD)

Ieq Capital LLC increased its position in Pediatrix Medical Group, Inc. (NYSE:MD) by 47.9% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 40,850 shares of the company’s stock after acquiring an additional 13,233 shares during the period. Ieq Capital LLC’s holdings in Pediatrix Medical Group were worth $536,000 at the end of the most recent reporting period.

A number of other hedge funds also recently added to or reduced their stakes in the company. Rubric Capital Management LP raised its holdings in Pediatrix Medical Group by 1.5% in the 3rd quarter. Rubric Capital Management LP now owns 8,275,000 shares of the company’s stock worth $95,907,000 after acquiring an additional 125,000 shares during the last quarter. State Street Corp raised its holdings in Pediatrix Medical Group by 1.4% in the 3rd quarter. State Street Corp now owns 3,540,791 shares of the company’s stock worth $41,038,000 after acquiring an additional 50,597 shares during the last quarter. Pacer Advisors Inc. purchased a new position in Pediatrix Medical Group in the 4th quarter worth approximately $35,492,000. Geode Capital Management LLC raised its stake in Pediatrix Medical Group by 2.4% during the 3rd quarter. Geode Capital Management LLC now owns 1,936,751 shares of the company’s stock valued at $22,452,000 after buying an additional 45,155 shares during the last quarter. Finally, Weiss Asset Management LP raised its stake in Pediatrix Medical Group by 50.5% during the 3rd quarter. Weiss Asset Management LP now owns 912,818 shares of the company’s stock valued at $10,580,000 after buying an additional 306,143 shares during the last quarter. 97.71% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on MD. Mizuho boosted their target price on shares of Pediatrix Medical Group from $13.00 to $15.00 and gave the company a “neutral” rating in a research note on Tuesday, November 19th. Jefferies Financial Group boosted their target price on shares of Pediatrix Medical Group from $14.00 to $18.00 and gave the company a “buy” rating in a research note on Tuesday, November 5th. StockNews.com upgraded shares of Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research note on Wednesday, January 22nd. Truist Financial boosted their target price on shares of Pediatrix Medical Group from $15.00 to $18.00 and gave the company a “hold” rating in a research note on Friday, February 21st. Finally, UBS Group boosted their target price on shares of Pediatrix Medical Group from $16.50 to $18.50 and gave the company a “neutral” rating in a research note on Friday, February 21st. Four research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Pediatrix Medical Group presently has an average rating of “Hold” and a consensus price target of $17.08.

Pediatrix Medical Group Trading Down 2.9 %

Shares of MD stock opened at $14.96 on Thursday. Pediatrix Medical Group, Inc. has a 1 year low of $6.62 and a 1 year high of $17.67. The firm has a fifty day moving average price of $13.96 and a 200-day moving average price of $13.11. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.60 and a quick ratio of 1.42. The company has a market cap of $1.28 billion, a price-to-earnings ratio of -12.47, a PEG ratio of 1.74 and a beta of 1.57.

Pediatrix Medical Group (NYSE:MD) last issued its earnings results on Thursday, February 20th. The company reported $0.49 earnings per share for the quarter, topping the consensus estimate of $0.37 by $0.12. The company had revenue of $502.36 million during the quarter, compared to the consensus estimate of $486.22 million. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. As a group, equities analysts predict that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current year.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.